Helveston E M, Knuth K R, Ellis F D
Department of Ophthalmology, Indiana Lions Eye Care Center, Indiana University School of Medicine, Indianapolis.
J Pediatr Ophthalmol Strabismus. 1987 Nov-Dec;24(6):296-300. doi: 10.3928/0191-3913-19871101-07.
Retinoblastoma was diagnosed in 74 patients between July 1967 and February 1987. Thirty cases (40%) were bilateral; 39 were female and 35 were male. Treatment in bilateral cases consisted of enucleation of the more involved eye and a combined approach of supervoltage irradiation, cryocoagulation, and photocoagulation to the remaining eye. In unilateral cases the involved eye was enucleated and the uninvolved eye observed. Four patients had bilateral enucleation at their initial presentation and four others had the second eye enucleated after unsuccessful tumor treatment. One patient died from metastatic retinoblastoma, one patient died after intrathecal chemotherapy without the evidence of tumor, and one patient died with trilateral retinoblastoma. Seventy-one of 74 patients (96%) currently survive with a follow-up of 1 month to 19 years. Two-year survival is 65 of 68 (95.5%).
1967年7月至1987年2月期间,74例患者被诊断为视网膜母细胞瘤。30例(40%)为双侧患病;39例为女性,35例为男性。双侧病例的治疗包括摘除受累更严重的眼睛,并对另一只眼睛采用超高压照射、冷冻凝固和光凝联合治疗方法。单侧病例则摘除患眼,观察未受累眼。4例患者初诊时双侧眼球均被摘除,另外4例患者在肿瘤治疗失败后摘除了另一只眼睛。1例患者死于视网膜母细胞瘤转移,1例患者在鞘内化疗后死亡,尸检未发现肿瘤,1例患者死于三侧性视网膜母细胞瘤。74例患者中有71例(96%)目前存活,随访时间为1个月至19年。68例患者中两年生存率为65例(95.5%)。